Form 4: Cryoport Director Exercises Options and Sells Shares Under Pre-Arranged Plan

Cryoport Inc. Director Ramkumar Mandalam exercised stock options and sold a portion of the resulting common stock on July 22, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Cryoport Inc. Director Ramkumar Mandalam exercised 60,000 stock options at an exercise price of $3.07 per share on July 22, 2025.
• Concurrently, Mandalam sold 40,728 shares of Cryoport common stock at a weighted average price of $7.2407 per share, with individual sales ranging from $6.75 to $7.49.
• The proceeds from the sale of common stock were utilized to cover the exercise price of the options and associated withholding taxes.
• These transactions were executed automatically as part of a Rule 10b5-1 trading plan adopted by Mandalam on June 10, 2025.
• Following these transactions, Mandalam directly beneficially owns 92,328 shares of Cryoport common stock and no derivative securities.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (exercise and sell-to-cover) under a pre-arranged plan, which is generally neutral in sentiment. It does not indicate positive or negative operational performance or strategic shifts.

Positives

• Director Mandalam successfully exercised stock options at a favorable price of $3.07, realizing a gain on the difference between the exercise price and the sale price.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and compliant approach to insider trading.

Negatives

• Director Mandalam reduced his direct beneficial ownership of Cryoport common stock by selling 40,728 shares.

Risks

• General market risk affecting the value of Cryoport's common stock.
• Potential for future sales by insiders, which could exert downward pressure on the stock price.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on past insider transactions.

Management Comments

• The transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025.
• The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option.
• The reported price for the common stock sale is a weighted average, with shares sold in multiple transactions ranging from $6.75 to $7.49.

Industry Context

This Form 4 filing details a routine insider transaction by a director of Cryoport, Inc., involving the exercise of stock options and a subsequent sale of shares. Such transactions are common for executives managing their equity compensation and typically do not reflect broader industry trends or competitive positioning, unless they are unusually large or frequent.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a director slightly increases the public float and could be perceived as a minor reduction in insider alignment, though it is common for tax and liquidity purposes.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request from Cryoport, Inc., any security holder, or the SEC staff.

Key Dates

Keywords

Cryoport, CYRX, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Director, Share Sale, Beneficial Ownership